These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33135827)

  • 1. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
    Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
    Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
    Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
    Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Cancer in the Indian Subcontinent-Survival Outcomes and Risk Factors with Primary Surgery.
    Thakar A; Thakur R; Kakkar A; Malhotra RK; Singh CA; Sikka K; Kumar R; Pramanik R; Biswas A; Bhalla AS; Bhaskar S; Sharma A
    Laryngoscope; 2021 Oct; 131(10):2254-2261. PubMed ID: 33797083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study.
    Lee J; Liu SH; Chen JC; Leu YS; Liu CJ; Chen YJ
    Radiother Oncol; 2021 May; 158():83-89. PubMed ID: 33621588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia results in poor survival rates in oral cavity cancer patients.
    Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
    Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
    Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
    Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
    Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
    Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer.
    Yamahara K; Mizukoshi A; Lee K; Ikegami S
    Auris Nasus Larynx; 2021 Oct; 48(5):1013-1022. PubMed ID: 33883097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study.
    Fridman E; Na'ara S; Agarwal J; Amit M; Bachar G; Villaret AB; Brandao J; Cernea CR; Chaturvedi P; Clark J; Ebrahimi A; Fliss DM; Jonnalagadda S; Kohler HF; Kowalski LP; Kreppel M; Liao CT; Patel SG; Patel RS; Robbins KT; Shah JP; Shpitzer T; Yen TC; Zöller JE; Gil Z;
    Cancer; 2018 Jul; 124(14):2948-2955. PubMed ID: 29757457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
    Ubachs J; Koole SN; Lahaye M; Fabris C; Bruijs L; Schagen van Leeuwen J; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham M; van Dam P; Vuylsteke P; Bastings J; Kruitwagen RFPM; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T; Sonke GS; van Driel WJ
    Gynecol Oncol; 2020 Dec; 159(3):706-711. PubMed ID: 33019981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria?
    Pillai V; Yadav V; Kekatpure V; Trivedi N; Chandrashekar NH; Shetty V; Rangappa V; Subramaniam N; Bhat V; Raghavan N; Kolur T; George N; Thomas T; Kuriakose MA
    Oral Oncol; 2019 Aug; 95():43-51. PubMed ID: 31345393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
    Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
    Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
    BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
    Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
    Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults.
    Gamez ME; Kraus R; Hinni ML; Moore EJ; Ma DJ; Ko SJ; Rwigema JCM; McGee LA; Halyard MY; Buras MR; Foote RL; Patel SH
    Oral Oncol; 2018 Dec; 87():43-48. PubMed ID: 30527242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.